Dermatology Commons^™

A Study Analysis Of A New Vitiligo Treatment: Patent Wo 20200588091a, Shaikha Al-Mousherji

Undergraduate Research Symposium

Abstract

Patent WO20200588091A in vitiligo treatment/methodology is a two-phase patent methodology and compositions for leukoderma treatment, patented by HSC researchers at Kuwait University-Kuwait. It is a day-and-night natural-based treatment that uses photosynthesizers followed by antioxidants and tyrosinase cofactors. The study aims to measure the effectiveness of the treatment.

Method

The data of this study was extracted from a hundred randomly selected patients through an online form of a questionnaire. The data covers the patient's demographics, awareness, previous vitiligo conventional treatments, and the patented treatment assessment.

Results

Data collection showed 52% of Females and 48% of Males were using the patented …

A Retrospective Observational Study: Is Absolute Lymphocyte Count A Prognostic Marker In Covid-19?, Mansoor Zafar, Muhammad Shahbaz, Mangala Karkhanis, Mohamed Abdelbagi, Opeyemi A. Makanjuola, Bipin Pun, Ratan S. Randhawa, Frederic Cuison, Dana Safarova, Najam-Us-Saher Rizvi

Section of Internal Medicine

Aim: Our study aimed to find a correlation between low absolute lymphocyte count and COVID-19-related mortality.
Methods: This study followed a retrospective observational cohort design to analyze the data of patients who presented with symptoms and signs of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), at the Conquest Hospital and Eastbourne District General Hospital in East Sussex, United Kingdom, between February 10, 2020 and May 1, 2020, retrospectively. Survival and mortality for the first 30 days and comorbidities were analyzed for all patients who were tested for COVID-19 irrespective of swab results and had blood lymphocyte levels taken at the …